The EU ombudsman has asked the EMA to explain redactions to clinical study reports (CSRs) for AbbVie's ($ABBV) Humira. The EMA responded quickly to the publication of ...
AUSTIN, Texas, April 20, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that the European Medicines Agency (EMA) rendered a negative “trend” vote after meeting with the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback